alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 00-50225 Conference Calendar

JUAN ROBERT RODRIGUEZ, also known as Juan Roberto Rodriguez, Petitioner-Appellant,

versus GARY L. JOHNSON, DIRECTOR, TEXAS DEPARTMENT OF CRIMINAL JUSTICE, INSTITUTIONAL DIVISION, Respondent-Appellee.

-------------------- Appeal from the United States District Court for the Western District of Texas USDC No. SA-99-CV-890-OG

-------------------- December 13, 2000 Before DAVIS, STEWART, and PARKER, Circuit Judges.

PER CURIAM: * Juan Robert Rodriguez, Texas prisoner #570369, seeks a certificate of appealability (“COA”) to appeal the denial of his petition for a writ of error coram nobis challenging his 1990 arson conviction, which the district court construed as a 28 U.S.C. § 2254 habeas corpus petition. Rodriguez argues that the district court erred in: treating his petition for a writ of coram nobis as a habeas petition; failing to consider the substance of his claims; and failing to award him coram nobis relief.No. 00-50225 -2- A COA is not required for an appeal from the denial of a petition for a writ of coram nobis. See 28 U.S.C. § 2253(c)(1); United States v. Dyer , 136 F.3d 417, 429 n.32 (5th Cir. 1998) (refusing to apply habeas law to a coram nobis case). However, “[i]t is well settled that the writ of error coram nobis is not available in federal court to attack state criminal judgments.” Sinclair v. Louisiana , 679 F.2d 513, 514 (5th Cir. 1982). Since Rodriguez’s petition challenged the validity of his state arson conviction, the district court lacked jurisdiction to grant him coram nobis relief and thus did not err in refusing to construe his petition as seeking such relief. To the extent that Rodriguez is challenging the district court’s denial of coram nobis relief, this appeal is DISMISSED. To the extent that Rodriguez is challenging the district court’s denial of habeas corpus relief, he has failed to demonstrate that the district court’s rejection on the merits of his claims of infirmities in the state habeas proceedings and procedural dismissal of his remaining claims were debatable or incorrect. See Slack v. McDaniel , 120 S. Ct. 1595, 1604 (2000). Rodriguez’s motions for a COA, for appointment of appellate counsel, and for leave to proceed in forma pauperis on appeal are

DENIED.
No. 09-8199.

#### Jonathan Bolls, Petitioner v. W. Scott Street, III, Secretary, Virginia Board of Bar Examiners.

559 U.S. 951, 130 S. Ct. 1535,

176 L. Ed. 2d 133,

2010 U.S. LEXIS 1438.

February 22, 2010.

Petition for writ of certiorari to the Supreme Court of Virginia denied.
I 

109TH CONGRESS 

2D SESSION H. R. 4910 

To prohibit the manufacture, sale, marketing, or distribution of products 

or substances designed or intended to defraud a drug test. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 8, 2006 

Mr. WHITFIELD (for himself and Mr. ENGEL) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To prohibit the manufacture, sale, marketing, or distribution 

of products or substances designed or intended to defraud a drug test. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘National Drug Testing 

5 Integrity Act’’. 

6 SEC. 2. FINDINGS AND PURPOSE. 

7 Congress finds the following: 

8 (1) Approximately 12,000,000 employees are 

9 subject to mandatory drug testing under Depart10 ment of Transportation regulations because they are 


rwilkins on PROD1PC63 with BILLS
2 

•HR 4910 IH 

1 in safety-sensitive positions. These employees include 

2 truck drivers, bus drivers, pilots, mass transit opera3 tors, railroad engineers, pipeline workers, mariners, 

4 and related transportation industry safety-sensitive 

5 personnel. 

6 (2) Millions of additional employers perform 

7 drug testing in an effort to increase safety, reduce 

8 employee turnover, tardiness, absenteeism, workers’ 

9 compensation claims, accidents and injuries, and 

10 health benefit utilization. 

11 (3) The availability of products designed to de12 fraud a drug test creates a serious public safety risk 

13 when employees in safety-sensitive positions are suc14 cessful in defrauding a drug test. 

15 (4) More than 400 products designed to de16 fraud drug tests are easily obtained, in person and 

17 on the Internet. 

18 SEC. 3. CONSUMER PRODUCT BAN. 

19 Not later than 180 days after the date of the enact20 ment of this Act, the Consumer Product Safety Commis21 sion shall, pursuant to section 9 of the Consumer Product 

22 Safety Act (15 U.S.C. 2058) and notwithstanding section 

23 8 of such Act (15 U.S.C. 2057), promulgate a rule declar24 ing to be a banned hazardous product any instrument, 

25 tool, substance, or device designed or intended to falsify, 


rwilkins on PROD1PC63 with BILLS
3 

•HR 4910 IH 

1 alter, or defraud any lawfully administered drug test de2 signed to detect the presence of chemical substances or 

3 controlled substances in the body. 

Æ 


rwilkins on PROD1PC63 with BILLS
---

CERTIFICATION OFCHIEF FINANCIAL OFFICERPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert D. McDougal, Chief Financial Officer of Ireland Inc. (the Company), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

|(i)  | the Quarterly Report on Form 10-QSB of the Company, for the fiscal quarter ended March 31, 2007, and to which this certification is attached as Exhibit 32.1 (the Report) fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|     |                                                                                                                                                                                                                                                                                                   
|(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.                                                                                                                                              

|By:    | /s/ Robert D.
      McDougal
|------ | ----------------------------
|Name:  | ROBERT D. McDOUGAL          
|Title: | Chief Financial Officer     
|Date:  | May 15, 2007                

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff
upon request.

This certification accompanies the Form 10-QSB to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or
the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-QSB), irrespective of any general incorporation language contained in such filing.

---
**Exhibit 31.1****CERTIFICATIONS**I, F. I. duPont, III, Chairman and CEO of First National Bancshares, Inc., certify that:1. I have reviewed this quarterly report on Form 10-Q of First National Bancshares, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to us by otherswithin those entities, particularly during the period in which this report is being prepared;**(b) [This paragraph intentionally left blank.]**(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on such evaluation;and(d) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):(a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.Date: November 9, 2005       /s/ F. I. duPont, III         F. I. duPont, III, Chairman & CEO
Jf ourtlj Court of Appeals'

grnii Antonio, Ccxns

September 30. 2014

No. 04-14-00004-CR, 04-14-00005-CR

04-14-00006-CR, and 04-14-00007-CR

Devon Alexander Kane.

Appellant

v.

State of Texas,

Appellee

Trial Court Case No. A1319

ORDER

The Court has reviewed the record and briefs in these appeals and has determined that

oral argument will not significantly aid it in determining the legal and factual issues presented in

the appeals. See Tex. R. App. P. 39.8. Therefore, all requests for oral argument are denied, and

the causes are advanced for ON BRIEFS submission on November 5. 2014. to the following

panel: Justice Martinez. Justice Alvarez, and Justice Chapa. All parties will be notified of the

Court's decision in these appeals in accordance with TEX. R. APP. P. 48.

Either party may file motion requesting the Court to reconsider its determination that

oral argument will not significantly aid the Court in determining the legal and factual issues

presented in the appeals. See '['EX. R. APP. P. 39.8. Such motion should be filed within ten (10)

days from the date of this order.

It is so ORDERED on September 30, 2014.

feebcof C. MarUHez. Justic

IN WITNESS WHEREOF, have hereunto sot my hand and a/iixed the seal o/thc said

court on this September 30, 2014.

€\lh li./iollie. Clerk'
No. 09-7824.

#### Gary Lawrence Ozenne, Petitioner v. Chase Manhattan Bank, et al.

559 U.S. 943, 130 S. Ct. 1510,

176 L. Ed. 2d 121,

2010 U.S. LEXIS 1458.

February 22, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Carrot Pound Cak

M4Z2
# C_2016342EN.01000901.xml

| 17.9.2016 | EN | Official Journal of the European Union | C 342/9 |
| --- | --- | --- | --- |

17.9.2016

EN

Official Journal of the European Union

C 342/9

---

Communication from the Minister for Economic Affairs of the Kingdom of the Netherlands pursuant to Article 3(2) of Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons

(2016/C 342/09)

The Minister for Economic Affairs hereby gives notice that an application has been received for authorisation to prospect for hydrocarbons in blocks G7, G10, G11 and G13 as indicated on the map appended as Annex 3 to the Mining Regulation (Mijnbouwregeling) (Government Gazette (Staatscourant) 2002, No 245).

Mijnbouwregeling

Staatscourant

With reference to the Directive referred to in the introduction and Article 15 of the Mining Act (Mijnbouwwet) (Bulletin of Acts and Decrees (Staatsblad) 2002, No 542), the Minister for Economic Affairs hereby invites interested parties to submit a competing application for authorisation to prospect for hydrocarbons in blocks G7, G10, G11 and G13 of the Dutch continental shelf.

Mijnbouwwet

Staatsblad

The Minister for Economic Affairs is the competent authority for the granting of authorisations. The criteria, conditions and requirements referred to in Articles 5(1), 5(2) and 6(2) of the abovementioned Directive are set out in the Mining Act (Bulletin of Acts and Decrees 2002, No 542).

Applications may be submitted during the 13 weeks following the publication of this notice in the Official Journal of the European Union and should be sent to:

Official Journal of the European Union

| The Minister for Economic Affairs |
| --- |
| attn.: Ms J.J. van Beek, Energy and Environment Directorate |
| Bezuidenhoutseweg 73 |
| Postbus 20401 |
| 2500 EK Den Haag |
| NEDERLAND |

The Minister for Economic Affairs

attn.: Ms J.J. van Beek, Energy and Environment Directorate

Bezuidenhoutseweg 73

Postbus 20401

2500 EK Den Haag

NEDERLAND

Applications received after the expiry of this period will not be considered.

A decision on the applications will be taken not later than 12 months after this period has expired.

Further information can be obtained by calling Mr S. van Lierop on the following telephone number: +31 655493868.

---
I 

109TH CONGRESS 

1ST SESSION H. R. 490 

To amend title XXVII of the Public Health Service Act to improve the 

affordability of health insurance coverage for small employers. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 1, 2005 

Mr. PENCE (for himself, Mr. SESSIONS, Mr. RYUN of Kansas, Mr. TANCREDO, 

Mr. GARRETT of New Jersey, Mr. FRANKS of Arizona, Mr. JONES of 

North Carolina, Mr. TERRY, Mr. WILSON of South Carolina, Mr. KING

of Iowa, Mr. PAUL, Mr. FLAKE, Mr. DOOLITTLE, Mr. MILLER of Florida, 

Mr. HOSTETTLER, Mr. SENSENBRENNER, Mrs. NORTHUP, Mr. BARRETT

of South Carolina, and Mr. SOUDER) introduced the following bill; which 

was referred to the Committee on Energy and Commerce 

A BILL 

To amend title XXVII of the Public Health Service Act 

to improve the affordability of health insurance coverage 

for small employers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Small Business 

5 Healthcare Savings Act’’. 
2 

•HR 490 IH 

1 SEC. 2. REPEAL OF GUARANTEED ISSUE IN SMALL GROUP 

2 MARKET. 

3 (a) IN GENERAL.—Subsection (a) of section 2711 of 

4 the Public Health Service Act (42 U.S.C. 300gg–11) is 

5 amended by striking ‘‘in a Statel’’ and all that follows 

6 through ‘‘must accept for enrollment’’ and inserting ‘‘in 

7 a State must accept for enrollment’’. 

8 (b) EFFECTIVE DATES.— 

9 (1) IN GENERAL.—Subject to paragraph (2), 

10 the amendments made by subsection (a) shall apply 

11 with respect to group health plans, and health insur12 ance coverage offered in connection with group 

13 health plans, for plan years beginning on or after 

14 January 1, 2006 (in this subsection referred to as 

15 the ‘‘general effective date’’) and also shall apply to 

16 portions of plan years occurring on and after such 

17 date. 

18 (2) TREATMENT OF COLLECTIVE BARGAINING

19 AGREEMENTS.—In the case of a group health plan 

20 maintained pursuant to 1 or more collective bar21 gaining agreements between employee representa22 tives and 1 or more employers ratified before the 

23 date of enactment of this Act, the amendments made 

24 by this Act shall not apply to plan years beginning 

25 before the later of— 
3 

•HR 490 IH 

1 (A) the date on which the last collective 

2 bargaining agreements relating to the plan ter3 minates (determined without regard to any ex4 tension thereof agreed to after the date of en5 actment of this Act); or 

6 (B) the general effective date. 

7 For purposes of subparagraph (A), any plan amendment 

8 made pursuant to a collective bargaining agreement relat9 ing to the plan which amends the plan solely to conform 

10 to any requirement added by this section shall not be 

11 treated as a termination of such collective bargaining 

12 agreement. 

Æ
Form of Award Notice under the Director's Restricted Stock Unit Plan



 Exhibit 10.36 
 November 12, 2009 
 Chrysler Group LLC 

2009 Directors’ Restricted Stock Unit Plan 
 Award Notice 
 [Name] 
 Dear             : 
 Chrysler Group LLC (the “Company”) is pleased to evidence and confirm its grant to you of 361,446 Restricted Stock Units (“RSUs”) pursuant to the Chrysler Group LLC 2009
Directors’ Restricted Stock Unit Plan (the “Directors’ RSU Plan”). The terms defined in the Directors’ RSU Plan have the same meanings in this Award Notice. This Award Notice and the RSUs evidenced by this Award Notice are
subject to and subordinate to the terms and conditions set forth in the Directors’ RSU Plan which is enclosed. 

120,482 of the RSUs evidenced by this Award Notice will vest if you continuously serve as a Director through June 10, 2010;
an additional 120,482 of the RSUs evidenced by this Award Notice will vest if you continuously serve as a Director through June 10, 2011; and, the remaining 120,482 RSUs evidenced by this Award Notice will vest if you continuously
serve as a Director through June 10, 2012. Except as provided in Section 5(b) (death or Disability) of the Directors’ RSU Plan, if you cease to serve as a Director for any reason prior to the applicable vesting dates set forth above,
the otherwise unvested RSUs then held by you shall be forfeited without payment as of the date you cease to be a Director. 
 An
amount equal to the Fair Market Value of the Chrysler Units underlying the vested RSUs credited to your RSU Account shall be paid to you in within 60 days following the date on which you cease to serve as a Director. 

 

			
	CHRYSLER GROUP LLC
		
	By:	 	  

		 	Stephen Wolf
                                        
Date
		 	Chair, Compensation and Leadership   Development Committee
	
	PARTICIPANT
	
	  

	    [Name]
                                         
           Date
No. 09-755.

#### Louis Dale Marcantel, Individually and in His Official Capacity as Chief of Police of the Village of Turkey Creek, Louisiana, Petitioner v. Michell B. Deville, et vir.

559 U.S. 1048, 130 S. Ct. 2343,

2010 U.S. LEXIS 3019.

176 L. Ed. 2d 561,

April 5, 2010.

Petition for writ of certio-rari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 567 F.3d 156.
# C_2016340EN.01000101.xml

| 16.9.2016 | EN | Official Journal of the European Union | C 340/1 |
| --- | --- | --- | --- |

16.9.2016

EN

Official Journal of the European Union

C 340/1

---

Commission statement relating to Regulation (EU) 2016/1627 of the European Parliament and of the Council of 14 September 2016 on a multiannual recovery plan for bluefin tuna in the eastern Atlantic and the Mediterranean, and repealing Council Regulation (EC) No 302/2009 (1)

1

(2016/C 340/01)

The Commission expresses concern that the limited powers delegated to it by the co-legislators may hinder the timely implementation in EU law of measures taken by ICCAT in the future that revise or update the control scheme of this organisation.

The Commission therefore declares that it considers this Regulation to be without prejudice to any future position of the institution as regards the recourse to Articles 290 and 291 TFEU for the transposition of regional fisheries management organisation measures.

The Commission furthermore reserves the right to propose amendments to the Regulation increasing the number of measures which should be adopted by delegated or implementing acts in case the transposition through the ordinary legislative procedure leads to delays which would jeopardise the EU's ability to comply with its international obligations.

---

(1)  OJ L 252, 16.9.2016, p. 1

1

---
No. 09-8796.

#### Charles Rathbun, Petitioner v. Mark Johnson, et al.

559 U.S. 1016, 130 S. Ct. 1905,

176 L. Ed. 2d 381,

2010 U.S. LEXIS 2722.

March 22, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 339 Fed. Appx. 704.
EXHIBIT 12.1

              CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Healthcare Technologies Ltd. on Form
20-F for the period ending December 31, 2004, filed with the Securities and
Exchange Commission on June 29, 2005, as amended on the date hereof (the
"Report"), I, Moshe Reuveni, Chief Executive Officer of Healthcare Technologies
Ltd., certify (pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002) that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of Healthcare
Technologies Ltd.

                                                    HEALTHCARE TECHNOLOGIES LTD.

                                                    By: /s/ Moshe Reuveni
                                                    ---------------------
                                                    Moshe Reuveni
                                                    Chief Executive Officer
Date:  July 1, 2005